Abstract: The present invention discloses an interactive system for neuromotor functioning assessment and training of a subject, using rhythmic-based techniques. The system may include an acquisition unit and an analysis unit connected by communication means. The acquisition unit may include measuring devices and may enable producing rhythmic aural and/or visual indications and measuring the subject's performing of actions under the produced rhythms. The actions may be carried out according to predefined exercises using the measuring devices. The analysis unit may include a software application that allows receiving, storing, displaying and analyzing of acquisition data arriving from the acquisition unit. At least one of the measuring devices may be a graphic-tool such as, for example, a digital pen connected to a receiver, enabling to measure the subject's lifting of the hand while performing graphical actions such as writing.

Abstract: A first aspect relates to an apparatus, system and method for calculating a driving behaviour risk indicator for a driver of a vehicle. Said aspect involves obtaining a count of events occurring in each of a plurality of predetermined categories based on inputs from an inertial unit mounted on the vehicle, the inertial unit including a 3D inertial sensor with 3D gyroscope functionality, each event being indicative of at least one of dangerous and aggressive driving; and calculating a driving behaviour risk indicator based on the number of events in each category. According to a second aspect, an apparatus and method for reconstructing a vehicle trajectory is provided. Said aspect includes updating a sensor error model.

Abstract: This invention relates to the new functional norbornanyl ester derivative and/or polymer compositions which are easily obtainable by reacting the Diels-Alder adduct of appropriate dienes and dienophiles with carboxylic acids. In particular, this invention relates to a new process for making cyclic chemical raw materials suitable for production coating, ink, adhesive, plasticizer, thermoplastic or thermosetting plastic and functional polymers.

Abstract: The present invention relates generally to the field of molecular biology and concerns a method for enhancing plant yield-related traits relative to control plants. More specifically, the present invention concerns a method for enhancing yield related traits in plants relative to control plants, by modulating, preferably increasing, expression in the roots of a plant, of a nucleic acid sequence encoding a 2-cysteine peroxiredoxin (2-Cys PRX); or by modulating expression of a nucleic acid encoding an ANN polypeptide in a plant. The present invention also concerns plants having modulated, preferably increased, expression in the roots, of a nucleic acid sequence encoding a 2-Cys PRX, or having modulated expression of a nucleic acid encoding an ANN polypeptide, which plants have enhanced yield-related traits relative to control plants. The invention also provides constructs useful in the methods of the invention.

Abstract: A method and apparatus for applying images to food items, such as toast, includes a controllable at least one controllable heating elements directed to as to be disposed along a surface of an associated food item. The heating element is controllable along the surface in accordance with stored image data to apply the image to a food item. Image data is receivable from a data device such as a smart phone, tablet or computer either via a direct data connection or via a wide area network such as the Internet. Images are retrievable in accordance with payment or sponsorship.

Abstract: Provided is a novel hair growth and hair restoration material having excellent efficacy in hair growth and hair restoration for both men and women, even when the components thereof are at ultra-dilute concentrations; the hair growth and hair restoration material being characterized in containing a steryl glucopyranoside, preferably a cholesteryl glucopyranoside, represented by general formula (I). (In the formula, Z represents a sterol residue from which the hydroxyl group attached to the 3-position of a cyclopentanohydrophenanthrene ring has been removed.

Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.

Abstract: The present invention relates to transcriptional control sequences derived from GL9 genes, wherein the transcriptional control sequences direct specific or preferential expression of an operably connected nucleotide sequence of interest in one or more parts of a plant seed.

Abstract: The present invention relates generally to the drought-specific expression of a nucleotide sequence of interest in one or more cells of a plant. In some particular embodiments, the present invention relates to the drought-specific expression of a nucleotide sequence of interest in wheat under the control of a Rab17 transcriptional control sequence.

Abstract: The present invention relates generally to transcriptional control sequences for effecting expression of a nucleotide sequence of interest in a plant. More particularly, the present invention relates to transcriptional control sequences that direct specific or preferential expression of an operably connected nucleotide sequence of interest in a plant seed or one or more particular cell or tissue types therein.

Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.

Abstract: Methods and apparatus for improving cognitive function within a human. The invention utilizes an implanted device, such as an implantable signal generator or an implantable pump, to affect tissue elements within a Papez circuit of the human brain as well as tissue upstream or downstream from the Papez circuit. The implanted device delivers treatment therapy to thereby improve cognitive function by the human. A sensor may be used to detect various symptoms of the cognitive disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate delivery of the stimulation and/or drug therapy.

Abstract: A carrying system is disclosed. The carrying system comprises a top strap assembly including one or more shoulder straps and an adjustable loop, wherein each of the one or more shoulder straps includes a narrow portion and the adjustable loop includes at least one elastomeric patch. The carrying system further comprises a bottom strap assembly including a fixed loop and a bottom strap, wherein the fixed loop includes at least one elastomeric patch. The carrying system further comprises one or more buckles connecting the top strap assembly to the bottom strap assembly.

Abstract: The present invention relates to boron transporters and, in particular, to boron transporters derived from plants. The present invention also relates to methods that utilize boron transporters, such as methods for modulating boron transport in cells and methods for determining the level or rate of boron transport in a cell or organism on the basis of the expression level of one or more boron transporters.

Abstract: Methods and apparatus for inducing neurogenesis within a human. An implantable signal generator is used to deliver high frequency stimulation to deep brain tissue elements. The implanted device delivers treatment therapy to the brain to thereby induce neurogenesis by the human. A sensor may be used to detect various symptoms of nervous system discovery. A microprocessor algorithm may then analyze the output from the sensor to regulate the stimulation and/or drug therapy delivered to the brain.

Abstract: The present invention relates generally to the field of molecular biology and concerns a method for enhancing various economically important yield-related traits in plants. More specifically, the present invention concerns a method for enhancing yield-related traits in plants by modulating expression in a plant of a nucleic acid encoding a GSBP-like polypeptide (GSBP: GT-Pase activating protein SH3 domain binding Protein). The present invention also concerns plants having modulated expression of a nucleic acid encoding a GSBP-like polypeptide, which plants have enhanced yield-related traits relative to control plants.

Abstract: This invention relates to the new functional norbornanyl ester derivative and/or polymer compositions which are easily obtainable by reacting the Diels-Alder adduct of appropriate dienes and dienophiles with carboxylic acids. In particular, this invention relates to a new process for making cyclic chemical raw materials suitable for production coating, ink, adhesive, plasticizer, thermoplastic or thermosetting plastic and functional polymers.

Abstract: The present invention relates generally to the field of molecular biology and concerns a method for enhancing various economically important yield-related traits in plants. More specifically, the present invention concerns a method for enhancing yield-related traits in plants by modulating expression in a plant of a nucleic acid encoding a Harpin-associated Factor G polypeptide (hereinafter termed HpaG”). The present invention also concerns plants having modulated expression of a nucleic acid encoding an HpaG polypeptide, which plants have enhanced yield-related traits relative to control plants. The invention also provides constructs comprising HpaG-encoding nucleic acids, useful in performing the methods of the invention. The present invention also provides a method for enhancing yield-related traits in plants relative to control plants, by modulating (preferably increasing) expression in a plant of a nucleic acid sequence encoding a SWITCH 2/SUCROSE NON-FERMENTING 2 (SWI2/SNF2) polypeptide.

Abstract: Methods and apparatus for screening patients prior to deep brain stimulation to treat cognitive function are provided. One or more patient parameters are processed to produce results. A comparison of the results to a threshold indicates the applicability of the deep brain stimulation therapy.